Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis

Journal of Periodontology

Volumn 76, Issue 10, 2005, Pages 1629-1636

  Gibson III, Frank C ^a   Savelli, Juan ^a   Van Dyke, Thomas E ^a   Genco, Caroline Attardo ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Bacteria; Human; Neutrophils; Phagocytosis

Indexed keywords

CYSTEINE PROTEINASE; GINGIPAIN; GINGIPAIN R; IMMUNOGLOBULIN G; LYSINE; OPSONIN; SEPHAROSE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NEUTROPHIL; NONHUMAN; PERIODONTAL DISEASE; PERIODONTITIS; PHAGOCYTOSIS; PORPHYROMONAS GINGIVALIS;

ADHESINS, BACTERIAL; ADULT; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CYSTEINE ENDOPEPTIDASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; NEUTROPHILS; OPSONIN PROTEINS; PERIODONTITIS; PHAGOCYTOSIS; PORPHYROMONAS GINGIVALIS;

EID: 27844563076     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.10.1629     Document Type: Article

References (47)

1. Kamma JJ, Nakou M, Manti FA. Predominant microflora of severe, moderate and minimal periodontal lesions in young adults with rapidly progressive periodontitis. J Periodontal Res 1995;30:66-72.
2. Page RC, Altman LC, Ebersole JL, et al. Rapidly progressive periodontitis. A distinct clinical condition. J Periodontol 1983;54:197-209.
3. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
4. Oliver RC, Brown LJ, Löe H. Periodontal diseases in the United States population. J Periodontol 1998; 69:269-278.
5. Nonnenmacher C, Mutters R, de Jacoby LF. Microbiological characteristics of subgingival microbiota in adult periodontitis, localized juvenile periodontitis and rapidly progressive periodontitis subjects. Clin Microbiol Infect 2001;7:213-217.
6. Landi L, Amar S, Polins AS, Van Dyke TE. Host mechanisms in the pathogenesis of periodontal disease. Curr Opin Periodontol 1997;4:3-10.
7. Laine ML, van Winkelhoff AJ. Virulence of six capsular serotypes of Porphyromonas gingivalis in a mouse model. Oral Microbiol Immunol 1998;13:322-325.
8. Potempa J, Banbula A, Travis J. Role of bacteria] proteinases in matrix destruction and modulation of host responses. Periodontol 2000 2000;24:153-192.
9. Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 1999;20:168-238.
10. Lamont RJ, Jenkinson HF. Subgingival colonization by Porphyromonas gingivalis. Oral Microbiol Immunol 2000;15:341-349.
11. Progulske-Fox A, Tumwasorn S, Lepine G, et al. The cloning, expression and sequence analysis of a second Porphyromonas gingivalis gene that codes for a protein involved in hemagglutination. Oral Microbiol Immunol 1995;10:311-318.
12. Pavloff N, Pemberton PA, Potempa J, et al. Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J Biol Chem 1997;272:1595-1600.
13. Nakagawa T, Sims T, Fan Q, et al. Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis. Oral Microbiol Immunol 2001;16:202-211.
14. Potempa J, Mikolajczyk-Pawlinska J, Brassell D, et al. Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalls. J Biol Chem 1998;273:21648-21657.
15. Pavloff N, Potempa J, Pike RN, et al. Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem 1995;270:1007-1010.
16. Pike RN, Potempa J, McGraw W, Coetzer TH, Travis J. Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol 1996;178:2876-2882.
17. Curtis MA, Aduse-Opoku J, Rangarajan M. Cysteine proteases of Porphyromonas gingivalis. Crit Rev Oral Biol Med 2001;12:192-216.
18. Sroka A, Sztukowska M, Potempa J, Travis J, Genco C. Degradation of host heme proteins by lysine- and arginine-specific cysteine proteinases (gingipains) of Porphyromonas gingivalis. J Bacteriol 2001;183: 5609-5616.
19. Olczak T, Dixon DW, Genco CA. Binding specificity of the Porphyromonas gingivalis heme and hemoglobin receptor HmuR, gingipain K, and gingipain R1 for heme, porphyrins, and metalloporphyrins. J Bacteriol 2001;183:5599-5608.
20. Genco CA, Potempa J, Mikolajczyk-Pawlinska J, Travis J. Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin Infect Dis 1999;28:456-465.
21. Kesavalu L, Holt SC, Ebersole JL. Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in a murine lesion model. Microb Pathog 1996;20:1-10.
22. O'Brien-Simpson NM, Paolini RA, Hoffmann B, Slakeski N, Dashper SG, Reynolds EC. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model. Infect Immun 2001;69:7527-7534.
23. Gibson FC 3rd, Genco CA. Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun 2001;69: 7959-7963.
24. Yonezawa H, Ishihara K, Okuda K. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model. Infect Immun 2001;69:2858-2864.
25. Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun 1998;66: 4108-4114.
26. Genco RJ. Current view of risk factors for periodontal diseases. J Periodontol 1996;67(Suppl):1041-1049.
27. Cutler CW, Kalmar JR, Arnold RR. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis. Infect Immun 1991;59:2105-2109.
28. Anderson DM, Ebersole JL, Novak MJ. Functional properties of nonhuman primate antibody to Porphyromonas gingivalis. Infect Immun 1995;63:3245-3252.
29. Wilton JM, Hurst TJ, Sterne JA. Elevated opsonic activity for Porphyromonas (Bacteroides) gingivalis in serum from patients with a history of destructive periodontal disease. A case: control study. J Clin Periodontol 1993;20:563-569.
30. Whitney C, Ant J, Moncla B, Johnson B, Page RC, Engel D. Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: Titer, avidity, and subclass distribution. Infect Immun 1992;60:2194-2200.
31. Mooney J, Kinane DF. Humoral immune responses to Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in adult periodontitis and rapidly progressive periodontitis. Oral Microbiol Immunol 1994;9:321-326.
32. Ogawa T, McGhee ML, Moldoveanu Z, et al. Bacteroides-specific IgG and IgA subclass antibody-secreting cells isolated from chronically inflamed gingival tissues. Clin Exp Immunol 1989;76:103-110.
33. Benjamin PA, Rogers PA, U S, Johnson NW, Cole MF, Curtis MA. Increased titre and avidity of IgG antibodies to Porphyromonas gingivalis whole cells and a cell surface protein in subjects with adult periodontitis. J Periodontal Res 1997;32:31-39.
34. O'Brien-Simpson NM, Black CL, Bhogal PS, et al. Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinase-adhesin complex of Porphyromonas gingivalis in adult periodontitis. Infect Immun 2000;68:2704-2712.
35. Inagaki S, Ishihara K, Yasaki Y, Yamada S, Okuda K. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis. J Periodontol 2003;74:1432-1439.
36. Wetzler LM, Blake MS, Barry K, Gotschlich E. Gonococcal porin vaccine evaluation: Comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. J Infect Dis 1992;166:551-555.
37. Kalmar JR, Arnold RR, Van Dyke TE. Direct interaction of Actinobacillus actinomycetemcomitans with normal and defective (LJP) neutrophils. J Periodontal Res 1987;22:179-181.
38. Cutler CW, Kalmar JR, Arnold RR. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect Immun 1991;59:2097-2104.
39. Lehmann AK, Halstensen A, Aaberge IS, et al. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect Immun 1999;67:2552-2560.
40. Lopatin DE, Blackburn E. Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients. Oral Microbiol Immunol 1992;7:332-337.
41. Califano JV, Schifferle RE, Gunsolley JC, Best AM, Schenkein HA, Tew JG. Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis. J Periodontol 1999;70:730-735.
42. Cutler CW, Arnold RR, Schenkein HA. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis. J Immunol 1993;151:7016-7029.
43. Mooney J, Kinane DF. Levels of specific immunoglobulin G to Porphyromonas gingivalis in gingival crevicular fluid are related to site disease status. Oral Microbiol Immunol 1997;12:112-116.
44. Zach MS. Lung disease in cystic fibrosis - An updated concept. Pediatr Pulmonol 1990;8:188-202.
45. Albus A, Saalmann M, Tesch H, Pedersen SS, Doring G. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis. APMIS 1989;97:1146-1148.
46. Bainbridge T, Fick RB Jr. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. J Lab Clin Med 1989;114:728-733.
47. Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990; 86:300-308.